Mary Kay Ladone

Insider Reports History

Location
130 East Randolph Street, Suite 1000, Chicago, IL
Signature
/s/ Mary Kay Ladone
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mary Kay Ladone:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Bioventus Inc. Director Class A Common Stock 79K $588K $7.44 Jun 2, 2025 Direct
Inogen Inc Director Common Stock 76.9K $559K $7.27 May 14, 2025 Direct
KESTRA MEDICAL TECHNOLOGIES, LTD. Director Common Shares 23.9K $430K $18.00 Sep 4, 2025 Direct
NOVANTA INC Director Restricted Stock Units 0 $225K $170.16 Jul 11, 2025 Direct
NOVANTA INC Director Common Stock 572 $69.7K $121.91 Jul 11, 2025 Direct
Bioventus Inc. Director Restricted Stock Units 32.3K $0 $4.75 Jun 3, 2025 Direct
Hill-Rom Holdings, Inc. SVP, Corp. Dev., Strat. & IR Common Stock 0 $155.73 Dec 13, 2021 Direct
Hill-Rom Holdings, Inc. SVP, Corp. Dev., Strat. & IR Performance-Based Restricted Stock Units (11/06/2019) 0 Dec 13, 2021 Direct
Hill-Rom Holdings, Inc. SVP, Corp. Dev., Strat. & IR Performance-Based Restricted Stock Units (11/11/2020) 0 Dec 13, 2021 Direct
Hill-Rom Holdings, Inc. SVP, Corp. Dev., Strat. & IR Restricted Stock Units (11/06/2019) 0 Dec 13, 2021 Direct
Hill-Rom Holdings, Inc. SVP, Corp. Dev., Strat. & IR Restricted Stock Units (11/07/2018) 0 Nov 8, 2021 Direct
Hill-Rom Holdings, Inc. SVP, Corp. Dev., Strat. & IR Restricted Stock Units (11/10/2021) 0 Dec 13, 2021 Direct
Hill-Rom Holdings, Inc. SVP, Corp. Dev., Strat. & IR Restricted Stock Units (11/11/2020) 0 Dec 13, 2021 Direct
Hill-Rom Holdings, Inc. SVP, Corp. Dev., Strat. & IR Employee Stock Option (Right to Buy) 0 $61.86 Dec 13, 2021 Direct

Insider Reports Filed by Mary Kay Ladone

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KMTS KESTRA MEDICAL TECHNOLOGIES, LTD. Sep 4, 2025 1 $0 4 Sep 8, 2025 Director
NOVT NOVANTA INC Jul 11, 2025 2 $0 4 Jul 14, 2025 Director
BVS Bioventus Inc. Jun 2, 2025 3 $0 4 Jun 4, 2025 Director
INGN Inogen Inc May 14, 2025 1 $0 4 May 16, 2025 Director
KMTS KESTRA MEDICAL TECHNOLOGIES, LTD. Mar 6, 2025 0 $0 3 Mar 6, 2025 Director
NOVT NOVANTA INC Jan 2, 2025 1 $0 4 Jan 6, 2025 Director
NOVT NOVANTA INC Jul 11, 2024 1 $0 4 Jul 15, 2024 Director
NOVT NOVANTA INC Jul 11, 2024 0 $0 3 Jul 12, 2024 Director
BVS Bioventus Inc. Jun 16, 2024 2 $0 4 Jun 18, 2024 Director
BVS Bioventus Inc. Jun 11, 2024 1 $0 4 Jun 13, 2024 Director
BVS Bioventus Inc. Jun 7, 2024 2 $0 4 Jun 11, 2024 Director
INGN Inogen Inc Jun 5, 2024 1 $0 4 Jun 7, 2024 Director
BVS Bioventus Inc. Jun 16, 2023 2 $0 4 Jun 20, 2023 Director
BVS Bioventus Inc. Jun 6, 2023 3 $0 4 Jun 8, 2023 Director
INGN Inogen Inc May 31, 2023 1 $0 4 Jun 2, 2023 Director
BVS Bioventus Inc. Jun 16, 2022 3 $0 4 Jun 22, 2022 Director
INGN Inogen Inc Jun 8, 2022 1 $0 4 Jun 10, 2022 Director
INGN Inogen Inc Mar 22, 2022 1 $0 4 Mar 24, 2022 Director
INGN Inogen Inc Mar 22, 2022 0 $0 3 Mar 24, 2022 Director
HRC Hill-Rom Holdings, Inc. Dec 13, 2021 8 -$591K 4 Dec 15, 2021 SVP, Corp. Dev., Strat. & IR
HRC Hill-Rom Holdings, Inc. Nov 12, 2021 3 -$39.2K 4 Nov 16, 2021 SVP, Corp. Dev., Strat. & IR
HRC Hill-Rom Holdings, Inc. Nov 10, 2021 4 -$123K 4 Nov 12, 2021 SVP, Corp. Dev., Strat. & IR
HRC Hill-Rom Holdings, Inc. Nov 8, 2021 12 -$292K 4 Nov 10, 2021 SVP, Corp. Dev., Strat. & IR
HRC Hill-Rom Holdings, Inc. Jul 28, 2021 8 -$1.16M 4 Jul 30, 2021 SVP, Corp. Dev., Strat. & IR
HRC Hill-Rom Holdings, Inc. Jul 23, 2021 7 -$1M 4 Jul 27, 2021 SVP, Corp. Dev., Strat. & IR
BVS Bioventus Inc. Jul 15, 2021 1 $0 4 Jul 19, 2021 Director
BVS Bioventus Inc. Jul 15, 2021 0 $0 3 Jul 19, 2021 Director